After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking this link: Communications
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Through communications with our clients, CTS is aware of the current national blood shortage. We rea...